← SearchA GENERIC HIGH-THROUGHPUT SCREENING PLATFORM FOR FRAGILE X, RETT SYNDROME, AND FRONTOTEMPORAL DEGENERATION USING HUMAN SYNTHETIC EMBRYOS$199,984FY2020Department of the ArmyDODRumi Scientific, Inc., New York NYInvestigatorsView source on USAspending →